Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cirrhosis Portal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07734896
What this trial is testing

Evaluating Novel Scoring Systems to Predict Outcomes in Acute-on-Chronic Liver Failure

Who this might be right for
Acute-on-Chronic Liver Failure (ACLF)Liver CirrhosisEnd Stage Liver Disease
Assiut University 100
Early research (Phase 1)Looking for participantsNCT06825559
What this trial is testing

Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease

Who this might be right for
Cholestatic Liver Disease
Zydus Therapeutics Inc. 6
Large-scale testing (Phase 3)Study completedNCT00794482
What this trial is testing

Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.

Who this might be right for
Hepatic Cirrhosis
Norgine 1,200
Testing effectiveness (Phase 2)Study completedNCT02230683
What this trial is testing

IDN-6556 in Cirrhotic Subjects With Portal Hypertension

Who this might be right for
Liver CirrhosisHepatic CirrhosisPortal Hypertension
Conatus Pharmaceuticals Inc. 23
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Early research (Phase 1)Study completedNCT00986895
What this trial is testing

Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group

Who this might be right for
Hepatic EncephalopathyUrea Cycle Disorders
Amgen 32
Testing effectiveness (Phase 2)UnknownNCT02171949
What this trial is testing

Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases

Who this might be right for
Chronic HepatitisHepatic Cirrhosis
Hospital Sao Rafael 30
Not applicableLooking for participantsNCT07561138
What this trial is testing

Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation

Who this might be right for
End-stage Liver DiseaseLiver CirrhosisLiver Transplantation+3 more
Kalliopi Anna Poulia 90
Not applicableStudy completedNCT01494064
What this trial is testing

Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care

Who this might be right for
Hepatic EncephalopathyLiver Cirrhosis
Assistance Publique - Hôpitaux de Paris 224
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Very early researchStudy completedNCT04814602
What this trial is testing

Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment

Who this might be right for
Cirrhosis, Liver
Georgetown University 11
Not applicableUnknownNCT06022237
What this trial is testing

Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.

Who this might be right for
Hepatic OsteodystrophyLiver Cirrhosis
Institute of Liver and Biliary Sciences, India 80
Not applicableStudy completedNCT00424957
What this trial is testing

Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System

Who this might be right for
CirrhosisHepatic Encephalopathy
University of Aarhus 18
Not applicableStudy completedNCT01267669
What this trial is testing

A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding

Who this might be right for
Acute Bleeding Esophageal VaricesPortal HypertensionCirrhosis
Govind Ballabh Pant Hospital 61
Not applicableUnknownNCT05251272
What this trial is testing

A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)

Who this might be right for
Portal Hypertension
Hepatopancreatobiliary Surgery Institute of Gansu Province 300
Post-approval studies (Phase 4)Study completedNCT00534677
What this trial is testing

The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed

Who this might be right for
Portal HypertensionCirrhosisHematemesis+1 more
Aga Khan University 320
Post-approval studies (Phase 4)Ended earlyNCT00548366
What this trial is testing

Sodium Restriction in the Management of Cirrhotic Ascites

Who this might be right for
Ascites
University of Texas Southwestern Medical Center 68
Not applicableActive Not RecruitingNCT07560202
What this trial is testing

Portal Vein Thrombosis in Liver Cirrhosis: Clinical Characteristics, Radiological Patterns, and Predictors

Who this might be right for
Liver CirrhosisPortal Vein Thrombosis
Elham Ahmed Hassan 240
Testing effectiveness (Phase 2)Study completedNCT00856869
What this trial is testing

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

Who this might be right for
Hepatic CirrhosisNonalcoholic Steatohepatitis
Norgine 52
Post-approval studies (Phase 4)Study completedNCT00955500
What this trial is testing

Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Hospital Universitari Vall d'Hebron Research Institute 116
Next Page